|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3000 USD | -.--% |
|
-.--% | - |
| 25-10-02 | Joint Disclosure Statement Approved for Irwin Naturals, Inc. | CI |
| 25-09-10 | Reorganization Plan Filed by Irwin Naturals, Inc. | CI |
| Market Cap | 485K 418K 384K 362K 680K 45.75M 686K 4.56M 1.77M 22.45M 1.82M 1.78M 77.67M | P/E 2021 |
105x | P/E 2022 | -0.94x |
|---|---|---|---|---|---|
| Enterprise Value | 21.01M 18.13M 16.67M 15.69M 29.48M 1.98B 29.72M 198M 76.89M 973M 78.87M 77.18M 3.37B | EV / Sales 2021 |
0.13x | EV / Sales 2022 | 0.32x |
| Free-Float |
1.04% | Yield 2021 * |
-
| Yield 2022 | - |
| 3 years | 0.05 |  | 1.5 |
| 5 years | 0.05 | | 4.75 |
| 10 years | 0.05 | | 4.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CEO | Chief Executive Officer | 60 | 1993-12-31 |
Mark Green
DFI | Director of Finance/CFO | - | 2024-03-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Klee Irwin
CHM | Chairman | 60 | 1993-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21-08-15 | Marche | Chief Executive Officer | 1 | - | ||
| 21-08-15 | Marche | Chief Executive Officer | 18,240 | - | ||
| 21-08-15 | Other | Chief Executive Officer | 0 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -80.00% | 721K | |
| -0.94% | -2.14% | +40.54% | +148.38% | 992B | |
| -0.42% | -1.80% | +53.69% | +42.60% | 564B | |
| -0.56% | -1.65% | +19.27% | +59.57% | 391B | |
| -1.04% | +0.68% | +24.66% | +16.53% | 330B | |
| -0.62% | -1.25% | +27.12% | +15.14% | 280B | |
| -0.57% | -0.76% | +27.01% | +32.77% | 279B | |
| -0.80% | -0.04% | -41.46% | -47.83% | 196B | |
| -1.78% | +1.16% | +17.79% | +48.77% | 184B | |
| -1.40% | +3.27% | +16.16% | +59.08% | 156B | |
| Average | -0.73% | +5.01% | +18.48% | +29.50% | 337.12B | |
| Weighted average by Cap. | -0.62% | -0.49% | +29.34% | +65.88% |
| 2021 | 2022 | |
|---|---|---|
| Net sales | 100M 86.57M 79.59M 74.91M 141M 9.47B 142M 943M 367M 4.65B 377M 369M 16.08B | 89.47M 77.19M 70.96M 66.79M 126M 8.44B 127M 841M 327M 4.14B 336M 329M 14.34B |
| Net income | 8.62M 7.43M 6.83M 6.43M 12.09M 813M 12.19M 80.98M 31.53M 399M 32.33M 31.64M 1.38B | -3.99M -3.44M -3.17M -2.98M -5.6M -377M -5.65M -37.52M -14.61M -185M -14.98M -14.66M -640M |
| Net Debt | 9.35M 8.07M 7.42M 6.98M 13.12M 883M 13.23M 87.91M 34.23M 433M 35.1M 34.35M 1.5B | 20.53M 17.71M 16.28M 15.32M 28.8M 1.94B 29.04M 193M 75.12M 951M 77.05M 75.4M 3.29B |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- IWIN Stock
Select your edition
All financial news and data tailored to specific country editions
